NEW SOURCE: See full news item from publisher
Company criticises Department of Health for failing to fulfil its Covid test contract
Omega Diagnostics has agreed to sell its diagnostic test kit manufacturing business and facility in Alva for £1m to Accubio.
Accubio is a wholly-owned subsidiary of Chinese firm Zhejiang Orient Gene Biotech.
The manufacturing business is being sold as a going concern, with approximately 109 full-time Scottish employees transferring across with the business; with no resultant redundancies.
The agreement also covers the sale of certain fixed assets, including plant and equipment – although not any government-funded equipment on site – as well as the assignment of the lease for the Alva site.
The agreement will contain transitional arrangements that address the ongoing requirements for the site to produce lateral flow tests for Omega, in particular the Visitect CD4 advanced disease test and the Visitect Covid-19 antigen test.
These arrangements will cover a transitionary period to December 2022.
The company will consider a number of options regarding the ongoing manufacture of the advanced disease test, one of which is the transfer to manufacturing at Omega’s planned new manufacturing site in Ely, Cambridgeshire.
Longer-term, Omega plans to move to a sub-contract manufacturing model for its COVID-19 antigen test, which is expected to significantly reduce manufacturing costs.
SEE FULL STORY: Business Insider